Pulsenmore announced today that it received FDA de novo clearance for its home-use prenatal ultrasound platform.
Pulsenmore’s FDA-approved home ultrasound device allows pregnant women to perform scans from home, revolutionizing pregnancy ...
"Pulsenmore stock up as at-home ultrasound secures FDA de novo authorisation" was originally created and published by Medical ...
Based on these scans, clinicians are able to assess fetal heartbeat, fetal movements, and amniotic fluid volume.
Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) ...
SARATOGA SPRINGS, N.Y. (WNYT) — Baby Bumps, an elective ultrasound facility in Saratoga Springs, is marking 15 years in business. The company provides an experience that allows parents to bond with ...